BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 8, 2009
View Archived Issues
MannKind Bulls, Bears Face off in Wake of Afresa Partner Delay
News that MannKind Corp. will not achieve its goal of signing a partnership this year for inhaled insulin product Afresa polarized the company's bullish backers and its bearish detractors. (BioWorld Today)
Read More
Epizyme's $32M to Fuel HMTs; Nobel Winner Helps the Push
Read More
Androxal Gives Repros Relief; Proellex, Cash Troubles Loom
Read More
Allos Expands Offering, Adds $100M for Folotyn Launch Prep
Read More
MIT Biochemist, Stem-Cell Ace Among National Medal Winners
Read More
Other News To Note
Read More
Clinic Roundup
Read More